Exceptional Responder to Immunotherapy: A Rare Case of Post-HSCT DLBCL Relapse Responding to Nivolumab

Immunotherapy is the treatment that either boosts the patient’s immune system or uses human-made versions of the normal parts of the immune system to kill lymphoma cells or slow their growth. A forty-eight-year-old lady with neck nodes, axillary nodes, weight loss and fever diagnosed to have Diffuse...

Descripción completa

Detalles Bibliográficos
Autores principales: Madabhavi, Irappa, KS, Sandeep, Sarkar, Malay, Modi, Mitul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660476/
https://www.ncbi.nlm.nih.gov/pubmed/31372200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660476/
https://www.ncbi.nlm.nih.gov/pubmed/31372200

Ejemplares similares